ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,698.83
      1.43%
      US Tech 100
      19,310.00
      2.40%
      Dow Jones
      41,960.80
      1.10%
      Brent Oil
      73.685
      1.80%
      Bitcoin
      62,964.53
      2.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Roivant Sciences Ltd (ROIV)

      7. Roivant Sciences Ltd (ROIV) Financials

      Roivant Sciences Ltd

      Roivant Sciences Ltd (ROIV)

      NASDAQ
      11.93
      -0.07
      ( -0.58% )
      Updated: 09:42:17
      Delayed by 15 minutes

      Roivant Sciences Ltd Financial Summary

      The current ROIV market cap is 8.82B. The company's latest EPS is USD 5.8807 and P/E is 2.04.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 21.62M37.1M37.14M28.93M55.13M
      Operating Income -276.41M-276.45M-287.53M-266M-230.57M
      Net Income -291.82M-304.33M5.1B-151.12M95.3M
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 67.69M23.8M55.29M61.28M124.8M
      Operating Income -553.81M-1.07B-1.35B-1.18B-1.11B
      Net Income 1.2B-809.23M-845.26M-1.01B4.35B

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.14B2.07B7.31B7.22B6.5B
      Total Liabilities 802.51M739.91M728.1M773.95M601.16M
      Total Equity 1.33B1.33B6.58B6.45B5.9B
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.48B2.59B2.59B2.39B7.22B
      Total Liabilities 368.36M527.69M523.7M782.02M773.95M
      Total Equity 2.09B2.04B2.04B1.61B6.45B

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -249.93M-446.36M-656.81M-765.27M-192.83M
      Investing 105k-36.35M5.2B5.2B-965k
      Financing 7.48M221.35M451.99M419.36M-660.62M
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -758.75M-552.14M-677.73M-843.39M-765.27M
      Investing 1.69B-31.7M303.3M-44.27M5.2B
      Financing 214.08M456.26M306.79M499.46M419.36M

      Stats and Ratios

      Market Cap 8.82B
      Price to Earnings Ratio 2.04
      Price to Sales Ratio 71.09
      Price to Cash Ratio 1.36
      Price to Book Ratio 1.38
      Dividend Yield -

      Share Statistics

      Shares Outstanding 739.52M
      Average Volume (1 week) 7.27M
      Average Volume (1 Month) 5.75M
      52 Week Change 7.28%
      52 Week High 13.24
      52 Week Low 8.245
      Spread (Intraday) 0.01 (0.08%)

      Company Info

      Company Name Roivant Sciences Ltd
      Address clarendon house
      hamilton D0 HM11
      Website https://www.roivant.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      ROIV
      Roivant Sciences
      Delayed Upgrade Clock